Testing a gene test using lung biopsy samples
Part of Cancer, Lungs & breathing clinical trials.
This study checks whether it’s practical to do gene (DNA) testing on samples taken during EBUS-TBNA, a common breathing-tube biopsy used to stage lung cancer. If it works well, it could make genetic testing faster and easier for people with lung cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older.
- You have confirmed or possibly lung cancer and need EBUS-TBNA to check lymph nodes in the middle of the chest (mediastinum).
- You have enlarged mediastinal lymph nodes that look suspicious for lung cancer and need a tissue diagnosis (a sample of tissue).
- Your care team must say it’s medically safe for you to have a bronchoscopy (a breathing-tube procedure).
- You should not be suspected to have lymphoma (a type of blood cancer) based on the clinical picture.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at using a scope with an ultrasound tip (EBUS-TBNA) to take small tissue samples from lymph nodes to figure out the cancer stage before stereotactic body radiotherapy (SBRT). The goal is to help confirm how far the cancer has spread so SBRT can be planned appropriately.
This study checks tiny pieces of DNA from a sample taken during a breathing-tube biopsy (EBUS-TBNA) to better identify certain lung cancer changes. It may help doctors learn more about the type of lung cancer and, in some cases, why targeted treatments stop working.
This study looks at special lab tests (molecular analysis) done on liquid taken during a bronchoscopy to better understand lung nodules. It may help doctors learn more about what these nodules are, using samples from the procedure.
This study compares two ways to get a larger tissue sample from lymph nodes in the chest after a first small test confirmed cancer. The goal is to see which method provides better material for detailed genetic testing (next generation sequencing) that can guide treatment choices.
This study looks at genetic (DNA) and molecular (cell-level) information related to lung cancer to better understand the disease. You may be invited if you have a confirmed primary lung cancer diagnosis, or if you are healthy with no cancer.
This study tests a new microscope that quickly analyzes lung tissue during a bronchoscopy or surgery. It may help doctors make faster, more accurate decisions about your care.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.